Entering text into the input field will update the search result below

Amgen Inc. (AMGN) Presents at 60th American Society of Hematology (ASH) Annual Meeting Presentation (Transcript)

Dec. 05, 2018 8:07 PM ETAmgen Inc. (AMGN)
SA Transcripts profile picture
SA Transcripts

Amgen Inc. (NASDAQ:AMGN) 60th American Society of Hematology Annual Meeting December 3, 2018 11:00 PM ET


Arvind Sood - VP, IR

Dr. David Reese - Head of R&D

Dr. Greg Friberg - VP, Global Development and Therapeutic Area Head for Oncology

Dr. Max Topp - Head of Hematology at University Hospital Wnrzburg, Germany


Geoff Porges - Leerink

Ying Huang - Bank of America-Merrill Lynch

Ronny Gal - Bernstein

Mike Yee - Jefferies

Kennen Mackay - RBC Capital

Terence Flynn - Goldman

Alethia Young - Cantor

Yaron Werber - Cowen and Company

Matt Phipps - William Blair

Evan Seigerman - Credit Suisse

Chris Richard - Tekla

Brian Skorney - Baird

Carter Gould - UBS

Arvind Sood

Okay, so we'll go on and get started. Good evening, everybody. I'd like to welcome you to our event this evening. And I know there are a lot of other events ongoing at the same time, but I think you made the right choice. So it's a great opportunity for us to, of course, talk about AMG 420 and other data that has been represented in the scientific sessions here at ASH, but it's also an opportunity for us to talk about the broader oncology portfolio.

So the presenters from the Amgen side are Dr. David Reese, he's our Head of Research and Development; and we also have Dr. Greg Friberg, who is our Vice President of Global Development and the Therapeutic Area Head for Oncology. I'm really delighted to have with us one of the lead investigators for AMG 420, Dr. Max Topp. He is also the Head of Hematology at the University Hospital in Wnrzburg, Germany.

So with that, David, I'd like to ask you to come up and make a few comments.

Dr. David Reese

Thanks Arvind and good evening

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.